Cytokinetics Inc (CYTK) stock
CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$51.65−1.52 (-2.86%)
Close on Nov 17, 2026Market cap $7.18BP/E –Yield –
Cytokinetics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cytokinetics's price to sales ratio was 0.1× on Nov 11, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.0× to 294.3×, with a median of 0.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.1× | +0.0 |
| 2025 | Dec 31, 2025 | 0.1× | −1.5 |
| 2024 | Dec 31, 2024 | 1.6× | +0.5 |
| 2023 | Dec 29, 2023 | 1.0× | +1.0 |
| 2022 | Dec 30, 2022 | 0.0× | −0.1 |
| 2021 | Dec 31, 2021 | 0.2× | +0.1 |
| 2020 | Dec 31, 2020 | 0.0× | −15.3 |
| 2019 | Apr 30, 2019 | 15.3× | −0.2 |
| 2018 | Dec 31, 2018 | 15.5× | +6.1 |
| 2017 | Dec 29, 2017 | 9.4× | +3.5 |
| 2016 | Dec 30, 2016 | 5.9× | −4.0 |
| 2015 | Dec 31, 2015 | 10.0× | +4.1 |
| 2014 | Dec 31, 2014 | 5.9× | −16.7 |
| 2013 | Dec 31, 2013 | 22.6× | +7.3 |
| 2012 | Dec 31, 2012 | 15.3× | −0.7 |
| 2011 | Dec 30, 2011 | 16.0× | +14.5 |
| 2010 | Dec 31, 2010 | 1.5× | – |
See a number that looks wrong?